Sign in

CIK 0001326732 · Accelerated filer

Ticker
XNCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
201622502
Phone
626-305-5900
Business address
465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,591,617
in 2 filings

Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-01 Valente Nancy EVP, Chief Development Officer Grant or award · Stock Options +235,778 235,778
2023-03-09 Yang Allen SR. VICE PRESIDENT & CMO Sale −1,094 $29.88 $33K 73,364
2023-03-09 Eckert Celia VP, GENERAL COUNSEL Sale −711 $29.88 $21K 36,976
2023-03-09 Kuch John J SR. VICE PRESIDENT & CFO Sale −711 $29.88 $21K 126,230
2023-03-09 Desjarlais John R SR. VICE PRESIDENT & CSO Sale −1,230 $29.88 $37K 147,726
2023-03-09 Dahiyat Bassil I PRESIDENT & CEO Sale −2,602 $29.88 $78K 249,701
2023-03-06 Yang Allen SR. VICE PRESIDENT & CMO Sale −4,069 $31.42 $128K 74,458
2023-03-06 Kuch John J SR. VICE PRESIDENT & CFO Sale −2,774 $31.42 $87K 126,941
2023-03-06 Eckert Celia VP, GENERAL COUNSEL Sale −2,462 $31.42 $77K 37,687
2023-03-06 Desjarlais John R SR. VICE PRESIDENT & CSO Sale −4,195 $31.42 $132K 148,956
2023-03-06 Dahiyat Bassil I PRESIDENT & CEO Sale −5,831 $31.42 $183K 252,303

Page 11 of 11 · 211 trades